Увійти

Готові списки джерел за темами / Bone resorption / Книги

Книги з теми "Bone resorption"

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Bone resorption.

Автор: Grafiati

Опубліковано: 4 червня 2021

Оновлено: 10 березня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 книг для дослідження на тему "Bone resorption".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте книги для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Felix, Bronner, Farach-Carson Mary C. 1958-, and Rubin Janet, eds. Bone resorption. London: Springer, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Bronner, Felix, Mary C. Farach-Carson, and Janet Rubin, eds. Bone Resorption. London: Springer-Verlag, 2005. http://dx.doi.org/10.1007/b136184.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Harvey, Wilson. Prostaglandins in bone resorption. Boca Raton, Fla: CRC Press, 1988.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Pierce, Angela Mary. Cellular mechanisms in bone and tooth resorption: Morphological studies in rats and monkeys. Stockholm: Kongl. Carolinska Medico Chirurgiska Institutet, 1988.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Brown, R. James. Histological and compositional responses of bone to immobilization and other experimental conditions: Semi-annual report. San Francisco, Calif: Institute of Chemical Biology, University of San Francisco, 1985.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Arun, Shanbhag, Rubash Harry E, and Jacobs Joshua J. 1956-, eds. Joint replacement and bone resorption: Pathology, biomaterials, and clinical practice. New York: Taylor & Francis, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Maria, Bijvoet Olav Leonardus, ed. Bisphosphonate on bones. Amsterdam: Elsevier, 1995.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Åkesson, Louise. Panoramic radiography in the assessment of the marginal bone level. Malmö: Department of Oral Radiology, Faculty of Odontology, Lund University, 1991.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Fleisch, Herbert. Bisphosphonates in bone disease: From the laboratory to the patient. Bern: H. Fleish, 1993.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Jonasson, Grethe. Mandibular alveolar bone mass, structure and thickness in relation to skeletal bone density in dentate women. Göteborg: Department of Orthodontics, Faculty of Odontology, The Sahlgrenska Academy at Göteborg University, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Loomer, Peter Michael. The direct effects of Porphyromonas Gingivalis 2561 on bone formation and mineral resorption in vitro. [Toronto: University of Toronto, Faculty of Dentistry], 1997.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Fleisch, Herbert. Bisphosphonates in bone disease: From the laboratory to the patient. 3rd ed. New York: Parthenon Pub. Group, 1997.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Fleisch, Herbert. Bisphosphonates in bone disease: From the laboratory to the patient. 2nd ed. New York: Parthenon Pub. Group, 1995.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Fleisch, Herbert. Bisphosphonates in bone disease: From the laboratory to the patient. 4th ed. San Diego: Academic Press, 2000.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

D, Rubens R., and European Conference on Clinical Oncology (5th : 1989 : London, England), eds. The Management of bone metastases and hypercalcaemia by osteoclast inhibition: An international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989. Toronto: Hogrefe & Huber, 1990.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Congress, European Society for Medical Oncology. Disodium pamidronate (APD) in the treatment of malignancy-related disorders: An international symposium held during the 13th Congress of the European Society for Medical Oncology (ESMO), Lugano, Switzerland, October 1988. Toronto: Hogrefe & Huber, 1990.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Peter, Burckhardt, ed. Disodium pamidronate (APD) in the treatment of malignancy-related disorders. Toronto: Huber, 1989.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Meyer, James L. I loved a boy: Confessions of a Roman Catholic priest. Royal Oak, Mich: Van Antwerp and Beale Publishers, 2007.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Meyer, James L. I loved a boy: Confessions of a Roman Catholic priest. Royal Oak, Mich: Van Antwerp and Beale Publishers, 2007.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Shorey, Seema. Differences in the degree to which osteoclasts from different parts of the skeleton employ cathepsin K and matrix metalloproteinases for bone resorption. Ottawa: National Library of Canada, 2002.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Tai, Victoria. The effects of leukotriene Bb4s on osteoclast formation and osteoclastic bone resorption and the role of osteoblastic cells in these processes. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Mundy, Gregory R. Bone remodeling and its disorders. London: Martin Dunitz, 1994.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Mundy, Gregory R. Bone remodeling and its disorders. London: Martin Dunitz, 1995.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Bronner, Felix, Janet Rubin, and Mary C. Farach-Carson. Bone Resorption. Springer London, Limited, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Bronner, Felix, Janet Rubin, and Mary C. Farach-Carson. Bone Resorption. Springer London, Limited, 2006.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Harvey, Wilson, and Alan Bennett. Prostaglandins in Bone Resorption. CRC Press, 2020. http://dx.doi.org/10.1201/9780429279195.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Harvey, Wilson, and Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Harvey, Wilson, and Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Harvey, Wilson, and Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Harvey, Wilson, and Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2019.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Harvey, Wilson, and Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Bone resorption, metastasis, and diphosphonates. New York: Raven Press, 1985.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Shanbhag, Arun, Harry E. Rubash, and Joshua J. Jacobs, eds. Joint Replacement and Bone Resorption. CRC Press, 2005. http://dx.doi.org/10.1201/b14138.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Rubash, Harry E., Arun Shanbhag, and Joshua J. Jacobs. Joint Replacement and Bone Resorption. Taylor & Francis Group, 2019.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

35

OGURA, HIDEAKI. Pharmacological Approach to the Study of the Formation and the Resorption Mechanism of Hard Tissues. MEDICO DENTAL MEDIA INTERNATIONAL, 1994.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Osteoblasts: Morphology, Functions and Clinical Implications. Nova Science Pub Inc, 2013.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Anderson, Paul, Borje Edgar Christopher Nordin, and Howard Arthur Morris. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Anderson, Paul, Borje Edgar Christopher Nordin, and Howard Arthur Morris. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Anderson, Paul, Howard A. Morris, and B. E. Christopher Nordin. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2017.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Anderson, Paul, Borje Edgar Christopher Nordin, and Howard Arthur Morris. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Rubash, Harry E., Arun Shanbhag, and Joshua J. Jacobs. Joint Replacement and Bone Resorption: Pathology, Biomaterials and Clinical Practice. Taylor & Francis Group, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

42

(Editor), Arun Shanbhag, Harry E. Rubash (Editor), and Joshua J. Jacobs (Editor), eds. Joint Replacement and Bone Resorption: Pathology, Biomaterials and Clinical Practice. Informa Healthcare, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Rubash, Harry E., Arun Shanbhag, and Joshua J. Jacobs. Joint Replacement and Bone Resorption: Pathology, Biomaterials and Clinical Practice. Taylor & Francis Group, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Mansfield, Ian David. The synthesis of novel agents which inhibit tumour-stimulated bone resorption. 1999.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

45

The relationship between bone mineral density and selected variables: An epidemiological perspective. 1990.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Javaid, Kassim. Paget’s disease of bone. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0274.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Paget’s disease of bone is an uncommon bone disorder with increased bone resorption and disorganized bone formation of woven bone. Its cause is unclear; there is a clear genetic component but additional environmental factors are important, given the reduction in severity and prevalence in the UK. Paget’s disease is usually asymptomatic and detected by an unexplained raised alkaline phosphatase on routine biochemistry. Symptoms include focal bone pain, including headache. Other symptoms include bone deformity and complications such as fracture and nerve conduction. Paget’s disease can sometimes present with immobilization-associated hypercalcaemia or high-output cardiac failure, and rarely can transform to an osteosarcoma. This chapter addresses the clinical features, diagnosis, and management of Paget’s disease of bone.

47

Effects of prostaglandin Eb2s on chick bone rudiments in vitro: Studies on bone resorption and formation. Ottawa: National Library of Canada, 1990.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Wordsworth, B. P. Skeletal dysplasias. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0150.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Bone is metabolically active throughout life and metabolic disturbances may have wide-ranging consequences that are not restricted to altering its mechanics. The study of some genetic bone diseases has already provided remarkable insights into the normal regulation of bone metabolism. Skeletal dysplasias are developmental disorders of the chondro-osseous tissues commonly resulting in short stature, which is often disproportionate. The underlying mutations are often in the structural genes encoding components of the matrix but may also involve growth factors or cell signalling. In contrast, the dysostoses tend to affect single bones or groups of bones, reflecting the transient nature of the many different signalling factors to which they are responsive during development. Abnormalities of bone density (high or low) may be due to primary deficiency of bone matrix synthesis (e.g. osteogenesis imperfecta and hypophosphatasia) but may also reflect an imbalance between bone formation and resorption. This may be caused by abnormalities of bone formation (e.g. hyperostosis/sclerosteosis and osteoporosis pseudoglioma syndrome) or bone resorption (e.g. classic osteopetrosis and fibrous dysplasia).

49

Ralston, Stuart H. Paget’s disease of bone. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0144.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Paget's disease of bone (PDB) affects up to 1% of people of European origin aged 55 years and above. It is characterized by focal abnormalities of bone remodelling which disrupt normal bone architecture, leading to expansion and reduced mechanical strength of affected bones. This can lead to various complications including deformity, fracture, nerve compression syndromes, and osteoarthritis, although many patients are asymptomatic. Genetic factors play a key role in the pathogenesis of PDB. This seems to be mediated by a combination of rare genetic variants which cause familial forms of the disease and common variants which increase susceptibility to environmental triggers. Environmental factors which have been suggested to predispose to PDB include viral infections, calcium and vitamin D deficiency, and excessive mechanical loading of affected bones. The diagnosis can be made by the characteristic changes seen on radiographs, but isotope bone scans are helpful in defining disease extent. Serum alkaline phosphatase levels can be used as a measure of disease activity. Inhibitors of bone resorption are the mainstay of medical management for PDB and bisphosphonates are regarded as the treatment of choice. Bisphosphonates are highly effective at reducing bone turnover in PDB and have been found to heal osteolytic lesions, and normalize bone histology. Although bisphosphonates can improving bone pain caused by elevated bone turnover, most patients require additional therapy to deal with symptoms associated with disease complications. It is currently unclear whether bisphosphonate therapy is effective at preventing complications of PDB.

50

Ralston, Stuart H. Paget’s disease of bone. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0144_update_001.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Анотація:

Paget’s disease of bone (PDB) affects up to 1% of people of European origin aged 55 years and above. It is characterized by focal abnormalities of bone remodelling which disrupt normal bone architecture, leading to expansion and reduced mechanical strength of affected bones. This can lead to various complications including deformity, fracture, nerve compression syndromes, and osteoarthritis, although many patients are asymptomatic. Genetic factors play a key role in the pathogenesis of PDB. This seems to be mediated by a combination of rare genetic variants which cause familial forms of the disease and common variants which increase susceptibility to environmental triggers. Environmental factors which have been suggested to predispose to PDB include viral infections, calcium and vitamin D deficiency, and excessive mechanical loading of affected bones. The diagnosis can be made by the characteristic changes seen on radiographs, but isotope bone scans are helpful in defining disease extent. Serum alkaline phosphatase levels can be used as a measure of disease activity. Inhibitors of bone resorption are the mainstay of medical management for PDB and bisphosphonates are regarded as the treatment of choice. Bisphosphonates are highly effective at reducing bone turnover in PDB and have been found to heal osteolytic lesions, and normalize bone histology. Although bisphosphonates can improving bone pain caused by elevated bone turnover, most patients require additional therapy to deal with symptoms associated with disease complications. It is currently unclear whether bisphosphonate therapy is effective at preventing complications of PDB.